- Home
- CPBI vs VNRX Comparison
CPBI vs VNRX Comparison
Compare CPBI & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPBI | VNRX |
|---|---|---|
| Founded | 2023 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.5M | 31.9M |
| IPO Year | 2023 | 2012 |
Fundamental Metrics
Financial Performance| Metric | CPBI | VNRX |
|---|---|---|
| Price | $17.55 | $0.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 4.9K | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ 0.80 | N/A |
| Revenue | N/A | ★ $1,233,511.00 |
| Revenue This Year | N/A | $68.22 |
| Revenue Next Year | N/A | $382.75 |
| P/E Ratio | $21.94 | ★ N/A |
| Revenue Growth | N/A | ★ 59.10 |
| 52 Week Low | $13.00 | $0.17 |
| 52 Week High | $17.87 | $0.94 |
Technical Indicators
Market Signals| Indicator | CPBI | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 42.45 |
| Support Level | $17.37 | $0.17 |
| Resistance Level | N/A | $0.27 |
| Average True Range (ATR) | 0.19 | 0.02 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 64.64 | 40.11 |
Price Performance
Historical ComparisonAbout CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.